Emily D Gutowski

MD | Rheumatologist


 17 E 102nd St, New York
    New York, 10029-5204

  212-659-8551    Maps & Directions
Emily D Gutowski is a New York, New York based rheumatologist who is specialized in Rheumatology. Active license number of Emily D Gutowski for Rheumatology is 321124 in New York.
Emily D Gutowski treat joint disease similar to orthopedists but do not perform surgeries. She diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Emily D Gutowski speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Specialization: Rheumatology
Credentials: MD
Gender:Female
Practice Address:17 E 102nd St, New York,
New York, 10029-5204
Phone:212-659-8551
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1699304006
NPI Enumeration Date: 07 Apr, 2020
NPI Last Update On: 08 Sep, 2025
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Emily D Gutowski are as mentioned below.
License NumberSpecializationStateStatus
321124Rheumatologist New YorkPrimary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 700 Hicksville Rd Ste 205,
Bethpage, New York
Zip: 11714-3472
Phone Number: --
Patients can reach Emily D Gutowski at 17 E 102nd St, New York, New York or can call to book an appointment on 212-659-8551. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 October, 2025.

Comments/ Reviews: